Collaborative Communication Could Improve HTN Rx Adherence

Share this content:
Collaborative Communication Could Improve HTN Rx Adherence
Collaborative Communication Could Improve HTN Rx Adherence

WEDNESDAY, Aug. 23, 2017 (HealthDay News) -- Health care providers can help boost patient adherence to antihypertensive medications by communicating more collaboratively with patients, and including discussion of socioeconomic challenges, according to a study published online Aug. 22 in Circulation: Cardiovascular Quality and Outcomes.

Antoinette Schoenthaler, Ed.D., an associate professor of medicine at the New York University School of Medicine in New York City, and colleagues examined recorded interactions between 92 patients and 27 health care providers at three practices serving a low-income New York City population. Blacks, women, and the unemployed made up the majority of the patients. The researchers focused on communication between patients and clinicians, and collected medication adherence data continuously during the three-month study with an electronic monitoring device.

Patients were three times less likely to take their medications if their providers didn't use a more collaborative style, such as asking open-ended questions, and ensuring they understood instructions, the investigators found. Patients were six times less likely to take their medications when providers didn't ask about potential challenges such as employment and housing (odds ratio, 6.03), an effect that was heightened in black patients (odds ratio, 8.01).

"When health care providers ask patients about life challenges or take the time to check their patient's understanding of instructions, it signals that their health care provider genuinely cares about them and provides the motivation and confidence to manage their health issues on their own," Schoenthaler said in a journal news release.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »